BioSpace News Archive

Business

LaVoieHealthScience Signs Eight New Clients in 1H:2019

LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced eight new client partnerships, additional hires and the launch of an investor relations thought leadership series.

July 29, 2019
·
3 min read
Policy

Recovery Activists and Parents to Join Together in Boston at Second Major Purdue Pharma Court Hearing

Massachusetts Superior Court will address the merits of the complaints filed against Purdue Pharma by Attorney General Maura Healy which Purdue is attempting to have dismissed.

July 29, 2019
·
2 min read
BioCapital

FDA clears new indications for existing Lyme disease tests that may help streamline diagnoses

Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease

July 29, 2019
·
3 min read
Pharm Country

Merck Receives Positive EU CHMP Opinion for ZERBAXA® 3g Dose (ceftolozane and tazobactam) for the Treatment of Adults with Hospital-Acquired Pneumonia (HAP), Including Ventilator-Associated Pneumonia (VAP)

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending ZERBAXA® 3g dose (ceftolozane and tazobactam) for an additional indication for the treatment of hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), in adults

July 29, 2019
·
7 min read
BIO Asia-Taiwan 2019 Showcased Biotech as the Region’s Next Growth Engine

Event Brought Together Biopharma Executives and Investors from Around the World for Deal Making and Partnering Opportunities

July 29, 2019
·
3 min read
Business

Revance to Release Second Quarter 2019 Financial Results on Monday, August 5, 2019

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, today announced that the company will release second quarter 2019 financial results on Monday, August 5, 2019 after the close of market

July 29, 2019
·
2 min read
Business

PerkinElmer Announces Financial Results for the Second Quarter of 2019

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the second quarter ended June 30, 2019.

July 29, 2019
·
31 min read
Policy

JANSSEN RECEIVES CHMP POSITIVE OPINION FOR STELARA® (USTEKINUMAB) RECOMMENDING APPROVAL FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE EU

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorisation in the European Union (EU).

July 29, 2019
·
12 min read
Drug Development

European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) as First-Line Treatment for Advanced Renal Cell Carcinoma

Opinion Granted Based on Significant Overall Survival Benefit for KEYTRUDA in Combination with Axitinib Compared to Sunitinib in Phase 3 KEYNOTE-426 Trial

July 29, 2019
·
33 min read
Business

Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine

Combines Mylan’s sustainable, diverse and differentiated portfolio of medicines with Upjohn’s trusted, iconic brands

July 29, 2019
·
22 min read